HomeBiotechnology

Biotechnology

Adaptive Biotechnologies (ADPT) Reports Q2 Loss, Tops Revenue Estimates

Adaptive Biotechnologies (ADPT) Reports Q2 Loss, Tops Revenue Estimates

August 10, 2020

ChemoCentryx (CCXI) Q2 Earnings and Revenues Surpass Estimates

ChemoCentryx (CCXI) Q2 Earnings and Revenues Surpass Estimates

August 10, 2020

Halozyme Therapeutics (HALO) Q2 Earnings and Revenues Lag Estimates

Halozyme Therapeutics (HALO) Q2 Earnings and Revenues Lag Estimates

August 10, 2020

How Will Biotech ETFs React to Q2 Earnings Release?

How Will Biotech ETFs React to Q2 Earnings Release?

August 10, 2020

Biohaven (BHVN) Q2 Earnings Beat on Strong Nurtec Uptake

Biohaven (BHVN) Q2 Earnings Beat on Strong Nurtec Uptake

August 10, 2020

Editas’ (EDIT) Earnings Beat in Q2, Revenues Improve Y/Y

Editas’ (EDIT) Earnings Beat in Q2, Revenues Improve Y/Y

August 10, 2020

Amicus’ (FOLD) Q2 Earnings Surpass Estimates, Revenues Miss

Amicus’ (FOLD) Q2 Earnings Surpass Estimates, Revenues Miss

August 10, 2020

5 Stocks in the Spotlight on Trump’s Coronavirus Vaccine Optimism

5 Stocks in the Spotlight on Trump’s Coronavirus Vaccine Optimism

August 10, 2020

BioMarin to Participate in Two Upcoming Virtual Investor Conferences

BioMarin to Participate in Two Upcoming Virtual Investor Conferences

August 10, 2020

Amicus Therapeutics (FOLD) Reports Q2 Loss, Misses Revenue Estimates

Amicus Therapeutics (FOLD) Reports Q2 Loss, Misses Revenue Estimates

August 10, 2020

« 1 … 512 513 514 515 516 … 543 »